Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study in Greek Patients with BPH for the Evaluation of Disease Control and QoL Under FDC Treatment with Solifenacin/tamsulosin

NCT06528613 is registered in ClinicalTrials.gov with Elpen Pharmaceutical Co. Inc. as lead sponsor.

NCT NCT06528613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06528613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study in Greek Patients with BPH for the Evaluation of Disease Control and QoL Under FDC Treatment with Solifenacin/tamsulosin
Lead sponsor
Elpen Pharmaceutical Co. Inc.
Phase
Observational
Overall status
Recruiting
Start date
October 23, 2024
Completion date
September 30, 2025
Enrollment
450 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia